Acupuncture preconditioning protects against myocardial ischemia/reperfusion injury mediated apoptosis through miR-214/NCX1 activation: a hypothesis

被引:0
作者
Fan, Hai-Long [1 ]
Ren, Yu-Lan [2 ]
Yang, Li-Zhen [1 ]
Wu, Fei [2 ]
机构
[1] Hohhot Hosp Mongolian Med & Tradit Chinese Med, 9 Bao Tou East St, Hohhot, Inner Mongolia, Peoples R China
[2] Chengdu Univ Tradit Chinese Med, Sch Acupuncture Moxibust & Tuina, Chengdu, Sichuan, Peoples R China
来源
TRADITIONAL MEDICINE RESEARCH | 2019年 / 4卷 / 04期
基金
中国国家自然科学基金;
关键词
MiR-214/NCX1; Acupuncture preconditioning; Coronary heart disease; Myocardial ischemia; Reperfusion injury; MICRORNA-214; PROTECTS; ISCHEMIA; HYPERTROPHY; INHIBITOR; EXCHANGER; SEA0400; HEART;
D O I
10.12032/TMR20190306109
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Early reperfusion of ischemic cardiac tissue is usually the best option to improve clinical outcome of angina pectoris, especially of acute myocardial infarction. However, myocardial reperfusion may cause an abnormal increase of intracellular Ca2+-mediated cardiomyocyte death and consequent loss of cardiac function, which is referred to myocardial ischemia/reperfusion (I/R) injury. Recently, the microRNA-214 (miR-214)/Na+/Ca2+ exchanger (NCX) 1 co-expression is a key factor in cellular protection against myocardial apoptosis for myocardial I/R injury. Once activated, miR-214/NCX1 axis can inhibit several Ca2+ downstream signaling effectors that mediate cell death simultaneously. Studies have shown that acupuncture preconditioning has a protective effect on myocardial I/R injury, but its mechanism deserves further research. It has been proved that acupuncture preconditioning for ischemic myocardium successfully inhibit multiple Ca2+ handling related microRNAs that mediate cell death pathways, and miR-214 is one of its targets. In terms of clinical practice, coronary heart disease (CHD) patients benefit a lot from this intervention. However, there is barely no study correlating acupuncture preconditioning to the miR-214/NCX1 co-expression in patients with CHD. This review aims to discuss whether there is some evidence to justify a recommendation of acupuncture preconditioning in CHD patients as a non-pharmacological therapeutic method to activate the miR-214/NCX1 co-expression network model.
引用
收藏
页码:178 / 183
页数:6
相关论文
共 35 条
  • [1] Chronic stable angina
    Abrams, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (24) : 2524 - 2533
  • [2] MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca2+ overload and cell death
    Aurora, Arin B.
    Mahmoud, Ahmed I.
    Luo, Xiang
    Johnson, Brett A.
    van Rooij, Eva
    Matsuzaki, Satoshi
    Humphries, Kenneth M.
    Hill, Joseph A.
    Bassel-Duby, Rhonda
    Sadek, Hesham A.
    Olson, Eric N.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (04) : 1222 - 1232
  • [3] Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling
    Dorn, Gerald W., II
    [J]. CARDIOVASCULAR RESEARCH, 2009, 81 (03) : 465 - 473
  • [4] Principles and effects of microRNA-mediated post-transcriptional gene regulation
    Engels, B. M.
    Hutvagner, G.
    [J]. ONCOGENE, 2006, 25 (46) : 6163 - 6169
  • [5] Myocardial Ischemia Reperfusion Injury: From Basic Science to Clinical Bedside
    FranK, Anja
    Bonney, Megan
    Bonney, Stephanie
    Weitzel, Lindsay
    Koeppen, Michael
    Eckle, Tobias
    [J]. SEMINARS IN CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2012, 16 (03) : 123 - 132
  • [6] Decoding calcium signals involved in cardiac growth and function
    Frey, N
    McKinsey, TA
    Olson, EN
    [J]. NATURE MEDICINE, 2000, 6 (11) : 1221 - 1227
  • [7] MicroRNA-1 Negatively Regulates Expression of the Hypertrophy-Associated Calmodulin and Mef2a Genes
    Ikeda, Sadakatsu
    He, Aibin
    Kong, Sek Won
    Lu, Jun
    Bejar, Rafael
    Bodyak, Natalya
    Lee, Kyu-Ho
    Ma, Qing
    Kang, Peter M.
    Golub, Todd R.
    Pu, William T.
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2009, 29 (08) : 2193 - 2204
  • [8] Kong Su-Ping, 2013, Zhongguo Zhen Jiu, V33, P529
  • [9] Lee C, 2004, CARDIOVASC DRUG REV, V22, P334
  • [10] Lin YP, 2006, J HUNAN COLL TRADIT, V26, P40